China Resources Pharmaceutical Group Ltd. (DE:640)
FRANKFURT:640
Holding DE:640?
Track your performance easily

China Resources Pharmaceutical Group Ltd. (640) Cash flow

0 Followers

China Resources Pharmaceutical Group Ltd. Cash Flow

DE:640's free cash flow for Q2 2022 was HK$―. For the 2022 fiscal year, DE:640's free cash flow was decreased by HK$3.71B and operating cash flow was HK$―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
-HK$ 12.84BHK$ 8.21BHK$ 8.14BHK$ 8.25BHK$ 4.86B
Investing Cash Flow
-HK$ -9.19BHK$ -2.25BHK$ 1.01BHK$ -9.80BHK$ -8.51B
Financing Cash Flow
-HK$ 3.01BHK$ -6.41BHK$ -13.01BHK$ 4.67BHK$ 3.13B
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-HK$ 17.53BHK$ 11.23BHK$ 12.55BHK$ 16.64BHK$ 14.17B
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-----HK$ 0.00
Issuance Of Debt
-HK$ 91.38BHK$ 59.59BHK$ 60.29BHK$ 84.95BHK$ 60.08B
Repayment Of Debt
-HK$ -87.15BHK$ -64.25BHK$ -79.88BHK$ -70.28BHK$ -54.35B
Free Cash Flow
-HK$ 9.70BHK$ 5.99BHK$ 6.10BHK$ 6.27BHK$ 2.85B
Domestic Sales
------
Foreign Sales
------
Currency in HKD

China Resources Pharmaceutical Group Ltd. Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis